Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Estradiol, ATC G03CA03
Opportunity Score
Confidence: 70%
Complexity: medium
719 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Open House (non-exclusive) for Estradiol (ATC G03CA03) rebate agreements under §130a SGB V, organized by AOK Bayern, covering Bayern region. Rolling admission from Aug 2026 to Jul 2028, with final deadline for contract conclusion on 03 June 2028. No estimated value provided. Only pharmaceutical companies may participate. Submission may be in paper (two originals) or electronic (qualified signature). Monthly cutoff for enrollment: 3rd of each month.
Strengths
Documents available
Open procedure
Medium complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible
- Submit signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
- Submit signed contract including appendix 'Festlegung der vertragsgegenständlichen Arzneimittel'
Buyer
Name
AOK Bayern - Die Gesundheitskasse
Location
München, DEU
Identifier
DE811695320
Lots (1)
Non-exclusive rebate agreements for the active substance Estradiol, ATC G03CA03. Contract term from 01.08.2026 to 31.07.2028. All qualified pharmaceutical companies may join at any time until 03.06.2028.
Procurement Details
Publication
14 Jun 2026
Deadline
03 Jun 2028, 10:00
Procedure
open
Contract
supplies
Language
DEU
Publication #
408430-2026
Classification
Performance: Germany
Documents (2)
Opportunity Score
Confidence: 70%
Complexity: medium
719 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation